Lawrence H Price, MD - Publications

Affiliations: 
Department of Psychiatry and Human Behavior Brown University, Providence, RI 
Website:
https://vivo.brown.edu/display/lpricemd

261 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Daniels TE, Zitkovsky EK, Laumann LE, Kunicki ZJ, Price DJ, Peterson AL, Dennery PA, Kao HT, Parade SH, Price LH, Abrantes AM, Tyrka AR. Circulating cell-free mitochondrial DNA (cf-mtDNA) and depressive symptoms among low-active adults who smoke. Psychosomatic Medicine. PMID 37769227 DOI: 10.1097/PSY.0000000000001254  0.578
2023 Daniels TE, Zitkovsky EK, Kunicki ZJ, Price DJ, Peterson AL, Dennery PA, Kao HT, Price LH, Tyrka AR, Abrantes AM. Corrigendum to "Associations of circulating cell-free DNA, C-reactive protein, and cardiometabolic risk among low-active smokers with elevated depressive symptoms" [Brain Behav. Immun. - Health 25 (2022) 100519]. Brain, Behavior, & Immunity - Health. 27: 100583. PMID 36714822 DOI: 10.1016/j.bbih.2022.100583  0.547
2022 Daniels TE, Zitkovsky EK, Kunicki ZJ, Price DJ, Peterson AL, Dennery PA, Kao HT, Price LH, Tyrka AR, Abrantes AM. Associations of circulating cell-free DNA, C-reactive protein, and cardiometabolic risk among low-active smokers with elevated depressive symptoms. Brain, Behavior, & Immunity - Health. 25: 100519. PMID 36164463 DOI: 10.1016/j.bbih.2022.100519  0.55
2020 Kokdere F, Tirrell E, Fukuda AM, Gobin AP, Kavanaugh B, Price LH, Carpenter LL. Do Deviations from the 5 Sessions per Week Schedule Impact Outcomes of Transcranial Magnetic Stimulation for Major Depressive Disorder? Brain Stimulation. PMID 32768691 DOI: 10.1016/J.Brs.2020.08.001  0.367
2020 Dichtel LE, Carpenter LL, Nyer M, Mischoulon D, Kimball A, Deckersbach T, Dougherty DD, Schoenfeld DA, Fisher L, Cusin C, Dording C, Trinh NH, Pedrelli P, Yeung A, Farabaugh A, ... ... Price LH, et al. Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study. The American Journal of Psychiatry. appiajp202019080844. PMID 32660299 DOI: 10.1176/Appi.Ajp.2020.19080844  0.646
2020 Ridout KK, Coe JL, Parade SH, Marsit CJ, Kao HT, Porton B, Carpenter LL, Price LH, Tyrka AR. Molecular markers of neuroendocrine function and mitochondrial biogenesis associated with early life stress. Psychoneuroendocrinology. 116: 104632. PMID 32199200 DOI: 10.1016/J.Psyneuen.2020.104632  0.569
2020 Dichtel LE, Carpenter LL, Nyer M, Mischoulon D, Kimball A, Deckersbach T, Dougherty DD, Schoenfeld D, Fisher L, Cusin C, Trinh N, Pedrelli P, Yeung A, Farabaugh A, Papakostas G, ... ... Price L, et al. SAT-737 Low-Dose Testosterone Augmentation for Treatment-Resistant Depression in Women: An 8-Week, Two-Site, Randomized, Placebo-Controlled Study Journal of the Endocrine Society. 4. DOI: 10.1210/Jendso/Bvaa046.081  0.637
2020 Daniels T, Zitkovsky E, Price D, Patterson A, Dennery P, Carpenter L, Price L, Tyrka A. Circulating Cell-Free Mitochondrial DNA (ccf-MtDNA) in Adults With and Without Early Adversity Following Acute Psychosocial Stressor: A Pilot Study Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.401  0.543
2019 Sakurai H, L Carpenter L, R Tyrka A, Price LH, I Papakostas G, Dording CM, Yeung AS, Cusin C, Ludington E, Bernard-Negron R, Fava M, Mischoulon D. Dose increase of S-Adenosyl-Methionine and escitalopram in a randomized clinical trial for major depressive disorder. Journal of Affective Disorders. 262: 118-125. PMID 31733455 DOI: 10.1016/J.Jad.2019.10.040  0.376
2019 Ridout KK, Parade SH, Kao HT, Magnan S, Seifer R, Porton B, Price LH, Tyrka AR. Corrigendum to "Childhood maltreatment, behavioral adjustment, and molecular markers of cellular aging in preschool-aged children: A cohort study" [Psychoneuroendocrinology 107 (2019) 261-269]. Psychoneuroendocrinology. 104466. PMID 31604578 DOI: 10.1016/J.Psyneuen.2019.104466  0.524
2019 Ridout KK, Parade SH, Kao HT, Magnan S, Seifer R, Porton B, Price LH, Tyrka AR. Childhood maltreatment, behavioral adjustment, and molecular markers of cellular aging in preschool-aged children: A cohort study. Psychoneuroendocrinology. 107: 261-269. PMID 31174164 DOI: 10.1016/J.Psyneuen.2019.05.015  0.541
2019 Ridout KK, Parade SH, Marsit CJ, Carpenter LL, Price LH, Philip NS, Kao H, Porton B, Tyrka AR. Neuroendocrine function and mitochondrial DNA copy number alterations with early stress and psychopathology Psychoneuroendocrinology. 100: S51. DOI: 10.1016/J.Psyneuen.2018.12.175  0.548
2019 Daniels T, Gaillard M, Carpenter L, Price L, Tyrka A. T151. Childhood Parental Loss, Maltreatment and Metabolic Risk in Healthy Young Adults Biological Psychiatry. 85: S187-S188. DOI: 10.1016/J.Biopsych.2019.03.474  0.528
2018 Gaudiano BA, Ellenberg S, Price LH, Moitra E. Time-lagged predictors of daily medication nonadherence beliefs during the month post-hospital discharge in patients with psychotic-spectrum disorders. Psychiatry Research. 270: 253-256. PMID 30269043 DOI: 10.1016/J.Psychres.2018.09.048  0.303
2018 Laferton JAC, Vijapura S, Baer L, Clain AJ, Cooper A, Papakostas G, Price LH, Carpenter LL, Tyrka AR, Fava M, Mischoulon D. Mechanisms of Perceived Treatment Assignment and Subsequent Expectancy Effects in a Double Blind Placebo Controlled RCT of Major Depression. Frontiers in Psychiatry. 9: 424. PMID 30245644 DOI: 10.3389/Fpsyt.2018.00424  0.648
2018 Carpenter LL, Conelea C, Tyrka AR, Welch ES, Greenberg BD, Price LH, Niedzwiecki M, Yip AG, Barnes J, Philip NS. 5 Hz Repetitive transcranial magnetic stimulation for posttraumatic stress disorder comorbid with major depressive disorder. Journal of Affective Disorders. 235: 414-420. PMID 29677606 DOI: 10.1016/J.Jad.2018.04.009  0.642
2018 Novick AM, Levandowski ML, Laumann LE, Philip NS, Price LH, Tyrka AR. The effects of early life stress on reward processing. Journal of Psychiatric Research. 101: 80-103. PMID 29567510 DOI: 10.1016/J.Jpsychires.2018.02.002  0.577
2018 Tyrka A, Ridout K, Parade S, Gaillard M, Seifer R, Kao H, Porton B, Price L, Bath K. 64. Early Stress and Mitochondrial DNA in Human and Mouse Models Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.081  0.537
2017 Abrantes AM, Farris SG, Garnaat SL, Minto A, Brown RA, Price LH, Uebelacker LA. The Role of Physical Activity Enjoyment on the Acute Mood Experience of Exercise among Smokers with Elevated Depressive Symptoms. Mental Health and Physical Activity. 12: 37-43. PMID 28989344 DOI: 10.1016/J.Mhpa.2017.02.001  0.369
2017 Philip NS, Barredo J, van 't Wout-Frank M, Tyrka AR, Price LH, Carpenter LL. Network Mechanisms of Clinical Response to Transcranial Magnetic Stimulation in Posttraumatic Stress Disorder and Major Depressive Disorder. Biological Psychiatry. PMID 28886760 DOI: 10.1016/J.Biopsych.2017.07.021  0.639
2017 Farris SG, Uebelacker LA, Brown RA, Price LH, Desaulniers J, Abrantes AM. Anxiety sensitivity predicts increased perceived exertion during a 1-mile walk test among treatment-seeking smokers. Journal of Behavioral Medicine. PMID 28451904 DOI: 10.1007/S10865-017-9853-Z  0.303
2017 Ridout KK, Levandowski M, Ridout SJ, Gantz L, Goonan K, Palermo D, Price LH, Tyrka AR. Early life adversity and telomere length: a meta-analysis. Molecular Psychiatry. 23: 858-871. PMID 28322278 DOI: 10.1038/Mp.2017.26  0.571
2017 Philip N, Barredo J, v 'ant Wout M, Almeida J, Tyrka A, Price L, Carpenter L. Network mechanisms of clinical response to TMS in Posttraumatic stress and major depressive disorders Brain Stimulation. 10: 356. DOI: 10.1016/J.Brs.2017.01.046  0.641
2017 Philip N, Barredo J, Wout Mv׳, Almeida J, Tyrka A, Price L, Carpenter L. 101. Network Mechanisms of Clinical Response to Transcranial Magnetic Stimulation in Posttraumatic Stress and Major Depressive Disorders Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.113  0.627
2016 Tyrka AR, Parade SH, Welch ES, Ridout KK, Price LH, Marsit C, Philip NS, Carpenter LL. Methylation of the leukocyte glucocorticoid receptor gene promoter in adults: associations with early adversity and depressive, anxiety and substance-use disorders. Translational Psychiatry. 6: e848. PMID 27378548 DOI: 10.1038/Tp.2016.112  0.637
2016 Philip NS, Tyrka AR, Albright SE, Sweet LH, Almeida J, Price LH, Carpenter LL. Early life stress predicts thalamic hyperconnectivity: A transdiagnostic study of global connectivity. Journal of Psychiatric Research. 79: 93-100. PMID 27214526 DOI: 10.1016/J.Jpsychires.2016.05.003  0.588
2016 Ridout KK, Parade SH, Carpenter LL, Price LH, Philip NS, Kao H, Porton B, Tyrka AR. 5.2 ASSOCIATION BETWEEN MOLECULAR MARKERS OF NEUROENDOCRINE FUNCTION AND CELLULAR METABOLISM WITH EARLY LIFE STRESS AND PSYCHOPATHOLOGY Journal of the American Academy of Child & Adolescent Psychiatry. 55: S184. DOI: 10.1016/J.Jaac.2016.09.261  0.555
2015 Ridout KK, Ridout SJ, Price LH, Sen S, Tyrka AR. Depression and telomere length: A meta-analysis. Journal of Affective Disorders. 191: 237-247. PMID 26688493 DOI: 10.1016/J.Jad.2015.11.052  0.623
2015 Philip NS, Carpenter SL, Ridout SJ, Sanchez G, Albright SE, Tyrka AR, Price LH, Carpenter LL. 5Hz Repetitive transcranial magnetic stimulation to left prefrontal cortex for major depression. Journal of Affective Disorders. 186: 13-7. PMID 26210705 DOI: 10.1016/J.Jad.2014.12.024  0.597
2015 Sarris J, Price LH, Carpenter LL, Tyrka AR, Ng CH, Papakostas GI, Jaeger A, Fava M, Mischoulon D. Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical Trial. Pharmacopsychiatry. 48: 141-4. PMID 26011569 DOI: 10.1055/S-0035-1549928  0.631
2015 Tyrka AR, Carpenter LL, Kao HT, Porton B, Philip NS, Ridout SJ, Ridout KK, Price LH. Association of telomere length and mitochondrial DNA copy number in a community sample of healthy adults. Experimental Gerontology. 66: 17-20. PMID 25845980 DOI: 10.1016/J.Exger.2015.04.002  0.603
2015 Ridout SJ, Ridout KK, Kao HT, Carpenter LL, Philip NS, Tyrka AR, Price LH. Telomeres, early-life stress and mental illness. Advances in Psychosomatic Medicine. 34: 92-108. PMID 25832516 DOI: 10.1159/000369088  0.587
2015 Philip NS, Sweet LH, Tyrka AR, Carpenter SL, Albright SE, Price LH, Carpenter LL. Exposure to childhood trauma is associated with altered n-back activation and performance in healthy adults: implications for a commonly used working memory task. Brain Imaging and Behavior. PMID 25804310 DOI: 10.1007/S11682-015-9373-9  0.564
2015 Tyrka AR, Parade SH, Price LH, Kao HT, Porton B, Philip NS, Welch ES, Carpenter LL. Alterations of Mitochondrial DNA Copy Number and Telomere Length with Early Adversity and Psychopathology. Biological Psychiatry. PMID 25749099 DOI: 10.1016/J.Biopsych.2014.12.025  0.575
2015 Minami H, Kahler CW, Bloom EL, Strong DR, Abrantes AM, Zywiak WH, Price LH, Brown RA. Effects of depression history and sex on the efficacy of sequential versus standard Fluoxetine for smoking cessation in elevated depressive symptom smokers Addictive Disorders and Their Treatment. 14: 29-39. DOI: 10.1097/Adt.0000000000000042  0.372
2015 Philip NS, Carpenter SL, Ridout SJ, Sanchez G, Albright SE, Tyrka AR, Price LH, Carpenter LL. 5 Hz Repetitive transcranial magnetic stimulation to left prefrontal cortex for major depression Journal of Affective Disorders. 186: 13-17. DOI: 10.1016/j.jad.2014.12.024  0.537
2014 Dougherty DD, Rezai AR, Carpenter LL, Howland RH, Bhati MT, O'Reardon JP, Eskandar EN, Baltuch GH, Machado AD, Kondziolka D, Cusin C, Evans KC, Price LH, Jacobs K, Pandya M, et al. A Randomized Sham-Controlled Trial of Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Chronic Treatment-Resistant Depression. Biological Psychiatry. PMID 25726497 DOI: 10.1016/J.Biopsych.2014.11.023  0.597
2014 Mischoulon D, Price LH, Carpenter LL, Tyrka AR, Papakostas GI, Fava M. Dr. Mischoulon and colleagues reply. The Journal of Clinical Psychiatry. 75: e1328-9. PMID 25470103 DOI: 10.4088/Jcp.14Lr09266A  0.506
2014 Ridout KK, Parade SH, Seifer R, Price LH, Gelernter J, Feliz P, Tyrka AR. Interleukin 1B gene (IL1B) variation and internalizing symptoms in maltreated preschoolers. Development and Psychopathology. 26: 1277-87. PMID 25422961 DOI: 10.1017/S0954579414001023  0.617
2014 Minami H, Kahler CW, Bloom EL, Prince MA, Abrantes AM, Strong DR, Niaura R, Miller IW, Palm Reed KM, Price LH, Brown RA. Effects of sequential fluoxetine and gender on prequit depressive symptoms, affect, craving, and quit day abstinence in smokers with elevated depressive symptoms: a growth curve modeling approach. Experimental and Clinical Psychopharmacology. 22: 392-406. PMID 25089930 DOI: 10.1037/A0037156  0.39
2014 Philip NS, Valentine TR, Sweet LH, Tyrka AR, Price LH, Carpenter LL. Early life stress impacts dorsolateral prefrontal cortex functional connectivity in healthy adults: informing future studies of antidepressant treatments. Journal of Psychiatric Research. 52: 63-9. PMID 24513500 DOI: 10.1016/J.Jpsychires.2014.01.014  0.598
2014 Mischoulon D, Price LH, Carpenter LL, Tyrka AR, Papakostas GI, Baer L, Dording CM, Clain AJ, Durham K, Walker R, Ludington E, Fava M. A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder. The Journal of Clinical Psychiatry. 75: 370-6. PMID 24500245 DOI: 10.4088/Jcp.13M08591  0.637
2014 Hantsoo L, Ward-O'Brien D, Czarkowski KA, Gueorguieva R, Price LH, Epperson CN. A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression. Psychopharmacology. 231: 939-48. PMID 24173623 DOI: 10.1007/S00213-013-3316-1  0.604
2014 Brown RA, Abrantes AM, Strong DR, Niaura R, Kahler CW, Miller IW, Price LH. Efficacy of sequential use of fluoxetine for smoking cessation in elevated depressive symptom smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 16: 197-207. PMID 24057928 DOI: 10.1093/Ntr/Ntt134  0.365
2013 Philip NS, Kuras YI, Valentine TR, Sweet LH, Tyrka AR, Price LH, Carpenter LL. Regional homogeneity and resting state functional connectivity: associations with exposure to early life stress. Psychiatry Research. 214: 247-53. PMID 24090510 DOI: 10.1016/J.Pscychresns.2013.07.013  0.585
2013 Case BG, Bertollo DN, Laska EM, Price LH, Siegel CE, Olfson M, Marcus SC. Declining use of electroconvulsive therapy in U.S. general hospitals is not restricted to unipolar depression. Biological Psychiatry. 74: e19-20. PMID 23786984 DOI: 10.1016/J.Biopsych.2013.01.039  0.321
2013 Tyrka AR, Burgers DE, Philip NS, Price LH, Carpenter LL. The neurobiological correlates of childhood adversity and implications for treatment. Acta Psychiatrica Scandinavica. 128: 434-47. PMID 23662634 DOI: 10.1111/Acps.12143  0.58
2013 Philip NS, Sweet LH, Tyrka AR, Price LH, Carpenter LL, Kuras YI, Clark US, Niaura RS. Early life stress is associated with greater default network deactivation during working memory in healthy controls: a preliminary report. Brain Imaging and Behavior. 7: 204-12. PMID 23269472 DOI: 10.1007/S11682-012-9216-X  0.575
2013 Philip NS, Sweet LH, Tyrka AR, Price LH, Bloom RF, Carpenter LL. Decreased default network connectivity is associated with early life stress in medication-free healthy adults. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 24-32. PMID 23141153 DOI: 10.1016/J.Euroneuro.2012.10.008  0.579
2013 Price LH, Kao HT, Burgers DE, Carpenter LL, Tyrka AR. Telomeres and early-life stress: an overview. Biological Psychiatry. 73: 15-23. PMID 22831981 DOI: 10.1016/J.Biopsych.2012.06.025  0.593
2013 Philip NS, Valentine TR, Kuras YI, Tyrka AR, Price LH, Carpenter LL. Regional homogeneity and resting state functional connectivity: associations with early life stress F1000research. 4. DOI: 10.7490/F1000Research.1093485.1  0.575
2012 Carpenter LL, Gawuga CE, Tyrka AR, Price LH. C-reactive protein, early life stress, and wellbeing in healthy adults. Acta Psychiatrica Scandinavica. 126: 402-10. PMID 22681496 DOI: 10.1111/J.1600-0447.2012.01892.X  0.607
2012 Philip NS, Carpenter LL, Tyrka AR, Price LH. The nicotinic acetylcholine receptor as a target for antidepressant drug development. Thescientificworldjournal. 2012: 104105. PMID 22619570 DOI: 10.1100/2012/104105  0.585
2012 Tyrka AR, Walters OC, Price LH, Anderson GM, Carpenter LL. Altered response to neuroendocrine challenge linked to indices of the metabolic syndrome in healthy adults. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Mã©Tabolisme. 44: 543-9. PMID 22549400 DOI: 10.1055/S-0032-1306342  0.608
2012 Tyrka AR, Price LH, Marsit C, Walters OC, Carpenter LL. Childhood adversity and epigenetic modulation of the leukocyte glucocorticoid receptor: preliminary findings in healthy adults. Plos One. 7: e30148. PMID 22295073 DOI: 10.1371/Journal.Pone.0030148  0.585
2012 McGuire JF, Storch EA, Lewin AB, Price LH, Rasmussen SA, Goodman WK. The role of avoidance in the phenomenology of obsessive-compulsive disorder. Comprehensive Psychiatry. 53: 187-94. PMID 21550030 DOI: 10.1016/J.Comppsych.2011.03.002  0.317
2012 Philip NS, Sweet LH, Tyrka AR, Price LH, Bloom RF, Carpenter LL. Towards imaging biomarkers of early life stress: decreased resting state default network connectivity F1000research. 3. DOI: 10.7490/F1000Research.1090528.1  0.617
2012 Gawuga C, Tyrka A, Price L, Carpenter L. 145. Temporal associations between IL-6 and cortisol production in response to acute psychosocial stress Brain, Behavior, and Immunity. 26: S40. DOI: 10.1016/J.Bbi.2012.07.169  0.571
2011 Carpenter LL, Tyrka AR, Lee JK, Tracy AP, Wilkinson CW, Price LH. A placebo-controlled study of sertraline's effect on cortisol response to the dexamethasone/corticotropin-releasing hormone test in healthy adults. Psychopharmacology. 218: 371-9. PMID 21617914 DOI: 10.1007/S00213-011-2336-Y  0.639
2011 Nierenberg AA, Leon AC, Price LH, Shelton RC, Trivedi MH. Crisis of confidence: antidepressant risk versus benefit. The Journal of Clinical Psychiatry. 72: e11. PMID 21450147 DOI: 10.4088/Jcp.10035Tx2C  0.413
2011 Cui D, Zhang H, Yang BZ, Listman JB, Li D, Price LH, Carpenter LL, Tyrka AR, Anton RF, Kranzler HR, Gelernter J. Variation in NGFB is associated with primary affective disorders in women. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 156: 401-12. PMID 21294249 DOI: 10.1002/Ajmg.B.31175  0.546
2011 Nugent NR, Tyrka AR, Carpenter LL, Price LH. Gene-environment interactions: early life stress and risk for depressive and anxiety disorders. Psychopharmacology. 214: 175-96. PMID 21225419 DOI: 10.1007/S00213-010-2151-X  0.642
2011 Carpenter LL, Shattuck TT, Tyrka AR, Geracioti TD, Price LH. Effect of childhood physical abuse on cortisol stress response. Psychopharmacology. 214: 367-75. PMID 20838776 DOI: 10.1007/S00213-010-2007-4  0.604
2011 Philip NS, Sweet LH, Tyrka AR, Price LH, Carpenter LL, Niaura R. Effects of early life stress on the default network F1000research. 2. DOI: 10.7490/F1000Research.1219.1  0.547
2010 Carpenter LL, Gawuga CE, Tyrka AR, Lee JK, Anderson GM, Price LH. Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2617-23. PMID 20881945 DOI: 10.1038/Npp.2010.159  0.609
2010 Philip NS, Carpenter LL, Tyrka AR, Price LH. Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature. Psychopharmacology. 212: 1-12. PMID 20614106 DOI: 10.1007/S00213-010-1932-6  0.622
2010 Storch EA, Rasmussen SA, Price LH, Larson MJ, Murphy TK, Goodman WK. Development and psychometric evaluation of the Yale-Brown Obsessive-Compulsive Scale--Second Edition. Psychological Assessment. 22: 223-32. PMID 20528050 DOI: 10.1037/A0018492  0.314
2010 Storch EA, Larson MJ, Price LH, Rasmussen SA, Murphy TK, Goodman WK. Psychometric analysis of the Yale-Brown Obsessive-Compulsive Scale Second Edition Symptom Checklist. Journal of Anxiety Disorders. 24: 650-6. PMID 20471199 DOI: 10.1016/J.Janxdis.2010.04.010  0.308
2010 Schoedl AF, Costa MC, Mari JJ, Mello MF, Tyrka AR, Carpenter LL, Price LH. The clinical correlates of reported childhood sexual abuse: an association between age at trauma onset and severity of depression and PTSD in adults. Journal of Child Sexual Abuse. 19: 156-70. PMID 20390785 DOI: 10.1080/10538711003615038  0.619
2010 Tyrka AR, Price LH, Carpenter LL, Anderson GM. In Reply to: Childhood Maltreatment and Hypothalamic-Pituitary-Adrenal Axis Reactivity. Biological Psychiatry. 67: e61-2. PMID 20207346 DOI: 10.1016/J.Biopsych.2009.12.036  0.549
2010 Philip NS, Carpenter LL, Tyrka AR, Price LH. Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era. Expert Opinion On Pharmacotherapy. 11: 709-22. PMID 20151847 DOI: 10.1517/14656561003614781  0.624
2010 Tyrka AR, Price LH, Kao HT, Porton B, Marsella SA, Carpenter LL. Childhood maltreatment and telomere shortening: preliminary support for an effect of early stress on cellular aging. Biological Psychiatry. 67: 531-4. PMID 19828140 DOI: 10.1016/J.Biopsych.2009.08.014  0.587
2010 Amin Z, Kanarek K, Krupitsky E, Walderhaug E, Ilomäki R, Blumberg H, Price LH, Bhagwagar Z, Carpenter LL, Tyrka AR, Magnusson A, Landrø NI, Zvartau E, Gelernter J, Epperson CN, et al. A sequencing-based survey of functional APAF1 alleles in a large sample of individuals with affective illness and population controls. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 332-5. PMID 19455599 DOI: 10.1002/Ajmg.B.30984  0.686
2010 Tyrka AR, Price LH, Kao HT, Porton B, Carpenter LL. In response to "no correlation between childhood maltreatment and telomere length" Biological Psychiatry. 68: e23-e24. DOI: 10.1016/J.Biopsych.2010.04.040  0.538
2009 Mello MF, Faria AA, Mello AF, Carpenter LL, Tyrka AR, Price LH. [Childhood maltreatment and adult psychopathology: pathways to hypothalamic-pituitary-adrenal axis dysfunction]. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 31: S41-8. PMID 19967199 DOI: 10.1590/S1516-44462009000600002  0.591
2009 Tyrka AR, Price LH, Gelernter J, Schepker C, Anderson GM, Carpenter LL. Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity. Biological Psychiatry. 66: 681-5. PMID 19596121 DOI: 10.1016/J.Biopsych.2009.05.012  0.61
2009 Carpenter LL, Ross NS, Tyrka AR, Anderson GM, Kelly M, Price LH. Dex/CRH test cortisol response in outpatients with major depression and matched healthy controls. Psychoneuroendocrinology. 34: 1208-13. PMID 19375869 DOI: 10.1016/J.Psyneuen.2009.03.009  0.659
2009 Carpenter LL, Tyrka AR, Ross NS, Khoury L, Anderson GM, Price LH. Effect of childhood emotional abuse and age on cortisol responsivity in adulthood. Biological Psychiatry. 66: 69-75. PMID 19375070 DOI: 10.1016/J.Biopsych.2009.02.030  0.612
2009 Philip NS, Carpenter LL, Tyrka AR, Whiteley LB, Price LH. Varenicline augmentation in depressed smokers: an 8-week, open-label study. The Journal of Clinical Psychiatry. 70: 1026-31. PMID 19323966 DOI: 10.4088/Jcp.08M04441  0.65
2009 Zuo L, Luo X, Listman JB, Kranzler HR, Wang S, Anton RF, Blumberg HP, Stein MB, Pearlson GD, Covault J, Charney DS, van Kammen DP, Price LH, Lappalainen J, Cramer J, et al. Population admixture modulates risk for alcohol dependence. Human Genetics. 125: 605-13. PMID 19306106 DOI: 10.1007/S00439-009-0647-4  0.457
2009 Tyrka AR, Wyche MC, Kelly MM, Price LH, Carpenter LL. Childhood maltreatment and adult personality disorder symptoms: influence of maltreatment type. Psychiatry Research. 165: 281-7. PMID 19162332 DOI: 10.1016/J.Psychres.2007.10.017  0.608
2009 Malone DA, Dougherty DD, Rezai AR, Carpenter LL, Friehs GM, Eskandar EN, Rauch SL, Rasmussen SA, Machado AG, Kubu CS, Tyrka AR, Price LH, Stypulkowski PH, Giftakis JE, Rise MT, et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biological Psychiatry. 65: 267-75. PMID 18842257 DOI: 10.1016/J.Biopsych.2008.08.029  0.609
2008 Tyrka AR, Wier L, Price LH, Ross NS, Carpenter LL. Childhood parental loss and adult psychopathology: effects of loss characteristics and contextual factors. International Journal of Psychiatry in Medicine. 38: 329-44. PMID 19069576 DOI: 10.2190/Pm.38.3.H  0.598
2008 Tyrka AR, Wier L, Price LH, Ross N, Anderson GM, Wilkinson CW, Carpenter LL. Childhood parental loss and adult hypothalamic-pituitary-adrenal function. Biological Psychiatry. 63: 1147-54. PMID 18339361 DOI: 10.1016/J.Biopsych.2008.01.011  0.563
2008 Philip NS, Mello K, Carpenter LL, Tyrka AR, Price LH. Patterns of quetiapine use in psychiatric inpatients: an examination of off-label use. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 20: 15-20. PMID 18297582 DOI: 10.1080/10401230701866870  0.576
2008 Tyrka AR, Wier LM, Price LH, Rikhye K, Ross NS, Anderson GM, Wilkinson CW, Carpenter LL. Cortisol and ACTH responses to the Dex/CRH test: influence of temperament. Hormones and Behavior. 53: 518-25. PMID 18294637 DOI: 10.1016/J.Yhbeh.2007.12.004  0.653
2008 Philip NS, Carpenter LL, Tyrka AR, Price LH. Augmentation of antidepressants with atypical antipsychotics: a review of the current literature. Journal of Psychiatric Practice. 14: 34-44. PMID 18212601 DOI: 10.1097/01.Pra.0000308493.93003.92  0.64
2008 Rikhye K, Tyrka AR, Kelly MM, Gagne GG, Mello AF, Mello MF, Price LH, Carpenter LL. Interplay between childhood maltreatment, parental bonding, and gender effects: impact on quality of life. Child Abuse & Neglect. 32: 19-34. PMID 18082260 DOI: 10.1016/J.Chiabu.2007.04.012  0.587
2008 Carpenter LL, Bayat L, Moreno F, Kling MA, Price LH, Tyrka AR, Kinkead B, Owens MJ, Nemeroff CB. Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy. Psychiatry Research. 157: 123-9. PMID 17976740 DOI: 10.1016/J.Psychres.2007.04.016  0.633
2008 Kelly MM, Tyrka AR, Price LH, Carpenter LL. Sex differences in the use of coping strategies: predictors of anxiety and depressive symptoms. Depression and Anxiety. 25: 839-46. PMID 17603810 DOI: 10.1002/Da.20341  0.591
2008 Kelly MM, Tyrka AR, Anderson GM, Price LH, Carpenter LL. Sex differences in emotional and physiological responses to the Trier Social Stress Test. Journal of Behavior Therapy and Experimental Psychiatry. 39: 87-98. PMID 17466262 DOI: 10.1016/J.Jbtep.2007.02.003  0.6
2007 Park MC, Goldman MA, Carpenter LL, Price LH, Friehs GM. Vagus nerve stimulation for depression: rationale, anatomical and physiological basis of efficacy and future prospects. Acta Neurochirurgica. Supplement. 97: 407-16. PMID 17691329 DOI: 10.1007/978-3-211-33081-4_46  0.399
2007 Price LH, Tyrka AR. Adjunctive antidepressant treatment for bipolar depression. The New England Journal of Medicine. 357: 614; author reply 61. PMID 17687139 DOI: 10.1056/Nejmc071459  0.641
2007 Grover KE, Carpenter LL, Price LH, Gagne GG, Mello AF, Mello MF, Tyrka AR. The relationship between childhood abuse and adult personality disorder symptoms. Journal of Personality Disorders. 21: 442-7. PMID 17685839 DOI: 10.1521/Pedi.2007.21.4.442  0.615
2007 Carpenter LL, Carvalho JP, Tyrka AR, Wier LM, Mello AF, Mello MF, Anderson GM, Wilkinson CW, Price LH. Decreased adrenocorticotropic hormone and cortisol responses to stress in healthy adults reporting significant childhood maltreatment. Biological Psychiatry. 62: 1080-7. PMID 17662255 DOI: 10.1016/J.Biopsych.2007.05.002  0.635
2007 Mello AF, Juruena MF, Pariante CM, Tyrka AR, Price LH, Carpenter LL, Del Porto JA. [Depression and stress: is there an endophenotype?]. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 29: S13-8. PMID 17546342 DOI: 10.1590/S1516-44462007000500004  0.655
2007 Tyrka AR, Wier LM, Anderson GM, Wilkinson CW, Price LH, Carpenter LL. Temperament and response to the Trier Social Stress Test. Acta Psychiatrica Scandinavica. 115: 395-402. PMID 17430418 DOI: 10.1111/J.1600-0447.2006.00941.X  0.606
2006 Tyrka AR, Mello AF, Mello MF, Gagne GG, Grover KE, Anderson GM, Price LH, Carpenter LL. Temperament and hypothalamic-pituitary-adrenal axis function in healthy adults. Psychoneuroendocrinology. 31: 1036-45. PMID 16908106 DOI: 10.1016/J.Psyneuen.2006.06.004  0.647
2006 Wier LM, Tavares SB, Tyrka AR, Price LH, Carpenter LL. Levetiracetam-induced depression in a healthy adult. The Journal of Clinical Psychiatry. 67: 1159-60. PMID 16889466 DOI: 10.4088/Jcp.V67N0721F  0.618
2006 Tyrka AR, Carpenter LL, Carvalho JP, Price LH. Biomarkers in the human stress system: do they signal risk for depression? Medicine and Health, Rhode Island. 89: 180-2. PMID 16764301  0.565
2006 Tyrka AR, Price LH, Mello MF, Mello AF, Carpenter LL. Psychotic major depression: a benefit-risk assessment of treatment options. Drug Safety. 29: 491-508. PMID 16752932 DOI: 10.2165/00002018-200629060-00003  0.653
2006 Carpenter LL, Friehs GM, Tyrka AR, Rasmussen S, Price LH, Greenberg BD. Vagus nerve stimulation and deep brain stimulation for treatment resistant depression. Medicine and Health, Rhode Island. 89: 137, 140-1. PMID 16676910  0.599
2006 Zhang H, Ozbay F, Lappalainen J, Kranzler HR, van Dyck CH, Charney DS, Price LH, Southwick S, Yang BZ, Rasmussen A, Gelernter J. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 141: 387-93. PMID 16649215 DOI: 10.1002/Ajmg.B.30332  0.463
2006 Geracioti TD, Carpenter LL, Owens MJ, Baker DG, Ekhator NN, Horn PS, Strawn JR, Sanacora G, Kinkead B, Price LH, Nemeroff CB. Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression. The American Journal of Psychiatry. 163: 637-43. PMID 16585438 DOI: 10.1176/Ajp.2006.163.4.637  0.388
2006 Carpenter LL, Schecter JM, Tyrka AR, Mello AF, Mello MF, Haggarty R, Price LH. Open-label tiagabine monotherapy for major depressive disorder with anxiety. The Journal of Clinical Psychiatry. 67: 66-71. PMID 16426090 DOI: 10.4088/Jcp.V67N0110  0.662
2005 Carpenter LL, Milosavljevic N, Schecter JM, Tyrka AR, Price LH. Augmentation with open-label atomoxetine for partial or nonresponse to antidepressants. The Journal of Clinical Psychiatry. 66: 1234-8. PMID 16259536 DOI: 10.4088/Jcp.V66N1005  0.653
2005 Phillips KA, Grant JE, Siniscalchi JM, Stout R, Price LH. A retrospective follow-up study of body dysmorphic disorder. Comprehensive Psychiatry. 46: 315-21. PMID 16122530 DOI: 10.1016/J.Comppsych.2004.12.001  0.308
2005 Carpenter LL, Schecter JM, Underwood JA, Tyrka AR, Price LH. Service expectations and clinical characteristics of patients receiving psychiatric emergency services. Psychiatric Services (Washington, D.C.). 56: 743-5. PMID 15939953 DOI: 10.1176/Appi.Ps.56.6.743  0.549
2005 Price LH. Book Review Anxiety Disorders in Adults: A Clinical Guide By Vladan Starcevic. 424 pp. New York, Oxford University Press, 2005. $59.50. 0-19-515606-4 New England Journal of Medicine. 352: 1727-1727. DOI: 10.1056/Nejm200504213521624  0.305
2004 Tyrka AR, Carpenter LL, McDougle CJ, Kirwin PD, Owens MJ, Nemeroff CB, Strong DR, Price LH. Increased cerebrospinal fluid corticotropin-releasing factor concentrations during tryptophan depletion in healthy adults. Biological Psychiatry. 56: 531-4. PMID 15450791 DOI: 10.1016/J.Biopsych.2004.06.035  0.583
2004 Carpenter LL, Moreno FA, Kling MA, Anderson GM, Regenold WT, Labiner DM, Price LH. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients. Biological Psychiatry. 56: 418-26. PMID 15364040 DOI: 10.1016/J.Biopsych.2004.06.025  0.353
2004 Carpenter LL, Heninger GR, Malison RT, Tyrka AR, Price LH. Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression. Journal of Affective Disorders. 79: 285-9. PMID 15023509 DOI: 10.1016/S0165-0327(02)00460-3  0.619
2004 Nelson JC, Mazure CM, Jatlow PI, Bowers MB, Price LH. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study. Biological Psychiatry. 55: 296-300. PMID 14744472 DOI: 10.1016/J.Biopsych.2003.08.007  0.376
2004 Carpenter LL, Tyrka AR, McDougle CJ, Malison RT, Owens MJ, Nemeroff CB, Price LH. Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 777-84. PMID 14702025 DOI: 10.1038/Sj.Npp.1300375  0.64
2004 Lappalainen J, Sanacora G, Kranzler HR, Malison R, Hibbard ES, Price LH, Krystal J, Gelernter J. Mutation screen of the glutamate decarboxylase-67 gene and haplotype association to unipolar depression. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 124: 81-6. PMID 14681921 DOI: 10.1002/Ajmg.B.20055  0.332
2003 Mello AF, Mello MF, Carpenter LL, Price LH. Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 25: 231-8. PMID 15328550 DOI: 10.1590/S1516-44462003000400010  0.42
2003 Carpenter LL, Friehs GM, Price LH. Cervical vagus nerve stimulation for treatment-resistant depression. Neurosurgery Clinics of North America. 14: 275-82. PMID 12856494 DOI: 10.1016/S1042-3680(02)00121-3  0.399
2003 Greenberg BD, Price LH, Rauch SL, Friehs G, Noren G, Malone D, Carpenter LL, Rezai AR, Rasmussen SA. Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues. Neurosurgery Clinics of North America. 14: 199-212. PMID 12856488 DOI: 10.1016/S1042-3680(03)00005-6  0.406
2002 Carpenter LL, Heninger GR, McDougle CJ, Tyrka AR, Epperson CN, Price LH. Cerebrospinal fluid interleukin-6 in obsessive-compulsive disorder and trichotillomania. Psychiatry Research. 112: 257-62. PMID 12450635 DOI: 10.1016/S0165-1781(02)00233-0  0.681
2002 Lappalainen J, Kranzler HR, Malison R, Price LH, Van Dyck C, Rosenheck RA, Cramer J, Southwick S, Charney D, Krystal J, Gelernter J. A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. Archives of General Psychiatry. 59: 825-31. PMID 12215082 DOI: 10.1001/Archpsyc.59.9.825  0.396
2002 Carpenter LL, Leon Z, Yasmin S, Price LH. Do obese depressed patients respond to topiramate? A retrospective chart review. Journal of Affective Disorders. 69: 251-5. PMID 12103474 DOI: 10.1016/S0165-0327(01)00337-8  0.405
2002 Cubells JF, Price LH, Meyers BS, Anderson GM, Zabetian CP, Alexopoulos GS, Nelson JC, Sanacora G, Kirwin P, Carpenter L, Malison RT, Gelernter J. Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression. Biological Psychiatry. 51: 358-64. PMID 11904129 DOI: 10.1016/S0006-3223(01)01349-X  0.315
2002 Carpenter LL, Yasmin S, Price LH. A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine. Biological Psychiatry. 51: 183-8. PMID 11822997 DOI: 10.1016/S0006-3223(01)01262-8  0.389
2002 Eisen JL, Rasmussen SA, Phillips KA, Price LH, Davidson J, Lydiard RB, Ninan P, Piggott T. Insight and treatment outcome in obsessive-compulsive disorder. Comprehensive Psychiatry. 42: 494-7. PMID 11704942 DOI: 10.1053/Comp.2001.27898  0.337
2002 Price LH. Treatment of Recurrent Depression. The Journal of Nervous and Mental Disease. 190: 204-205. DOI: 10.1097/00005053-200203000-00013  0.381
2001 Yasmin S, Carpenter LL, Leon Z, Siniscalchi JM, Price LH. Adjunctive gabapentin in treatment-resistant depression: a retrospective chart review. Journal of Affective Disorders. 63: 243-7. PMID 11246103 DOI: 10.1016/S0165-0327(00)00187-7  0.447
2000 Gagné GG, Furman MJ, Carpenter LL, Price LH. Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. The American Journal of Psychiatry. 157: 1960-5. PMID 11097961 DOI: 10.1176/Appi.Ajp.157.12.1960  0.395
2000 McDougle CJ, Epperson CN, Pelton GH, Wasylink S, Price LH. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Archives of General Psychiatry. 57: 794-801. PMID 10920469 DOI: 10.1001/Archpsyc.57.8.794  0.599
2000 Desan PH, Oren DA, Malison R, Price LH, Rosenbaum J, Smoller J, Charney DS, Gelernter J. Genetic polymorphism at the CLOCK gene locus and major depression American Journal of Medical Genetics - Neuropsychiatric Genetics. 96: 418-421. PMID 10898925 DOI: 10.1002/1096-8628(20000612)96:3<418::Aid-Ajmg34>3.0.Co;2-S  0.489
2000 Carpenter LL, Price LH. Psychotic depression: what is it and how should we treat it? Harvard Review of Psychiatry. 8: 40-2. PMID 10824297 DOI: 10.3109/Hrp.8.1.40  0.442
1999 Malison RT, Anand A, Pelton GH, Kirwin P, Carpenter L, McDougle CJ, Heninger GR, Price LH. Limited efficacy of ketoconazole in treatment-refractory major depression. Journal of Clinical Psychopharmacology. 19: 466-70. PMID 10505589 DOI: 10.1097/00004714-199910000-00011  0.433
1999 Longhurst JG, Carpenter LL, Epperson CN, Price LH, McDougle CJ. Effects of catecholamine depletion with AMPT (alpha-methyl-para-tyrosine) in obsessive-compulsive disorder. Biological Psychiatry. 46: 573-6. PMID 10459409 DOI: 10.1016/S0006-3223(99)00019-0  0.612
1999 Carpenter LL, Leon Z, Yasmin S, Price LH. Clinical experience with mirtazapine in the treatment of panic disorder. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 11: 81-6. PMID 10440525 DOI: 10.1023/A:1022394415585  0.389
1999 Bruder GE, Stewart JW, Wexler BE, Price LH, Quitkin FM. Perceptual asymmetry differences between major depression with or without a comorbid anxiety disorder: A dichotic listening study Journal of Abnormal Psychology. 108: 233-239. PMID 10369033 DOI: 10.1037//0021-843X.108.2.233  0.393
1999 Epperson CN, Fasula D, Wasylink S, Price LH, McDougle CJ. Risperidone addition in serotonin reuptake inhibitor-resistant trichotillomania: three cases. Journal of Child and Adolescent Psychopharmacology. 9: 43-9. PMID 10357517 DOI: 10.1089/Cap.1999.9.43  0.564
1999 Goddard AW, Woods SW, Money R, Pande AC, Charney DS, Goodman WK, Heninger GR, Price LH. Effects of the CCK(B) antagonist CI-988 on responses to mCPP in generalized anxiety disorder Psychiatry Research. 85: 225-240. PMID 10333376 DOI: 10.1016/S0165-1781(99)00015-3  0.468
1999 McDougle CJ, Barr LC, Goodman WK, Price LH. Possible role of neuropeptides in obsessive compulsive disorder. Psychoneuroendocrinology. 24: 1-24. PMID 10098217 DOI: 10.1016/S0306-4530(98)00046-8  0.368
1999 Carpenter LL, Jocic Z, Hall JM, Rasmussen SA, Price LH. Mirtazapine augmentation in the treatment of refractory depression. The Journal of Clinical Psychiatry. 60: 45-9. PMID 10074878 DOI: 10.4088/Jcp.V60N0110  0.425
1999 Price LH, Rasmussen SA, Eisen JL. The natural history of obsessive-compulsive disorder. Archives of General Psychiatry. 56: 131-2. PMID 10025436 DOI: 10.1001/Archpsyc.56.2.131  0.301
1999 Cappiello A, McDougle CJ, Delgado PL, Malison RT, Jatlow P, Charney DS, Heninger GR, Price LH. Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study. International Clinical Psychopharmacology. 13: 191-8. PMID 9817623 DOI: 10.1097/00004850-199809000-00001  0.56
1998 Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L, Sanacora G, Owens MJ, Nemeroff CB, Rajeevan N, Baldwin RM, Seibyl JP, Innis RB, Charney DS. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biological Psychiatry. 44: 1090-8. PMID 9836013 DOI: 10.1016/S0006-3223(98)00272-8  0.506
1998 McDougle CJ, Epperson CN, Price LH, Gelernter J. Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder Molecular Psychiatry. 3: 270-273. PMID 9672904 DOI: 10.1038/Sj.Mp.4000391  0.556
1998 McDougle CJ, Holmes JP, Carlson C, Pelton GH, Cohen DJ, Price LH. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders Archives of General Psychiatry. 55: 633-641. PMID 9672054 DOI: 10.1001/Archpsyc.55.7.633  0.341
1998 Sernyak MJ, Glazer WM, Heninger GR, Charney DS, Woods SW, Petrakis IL, Krystal JH, Price LH. Naltrexone augmentation of neuroleptics in schizophrenia. Journal of Clinical Psychopharmacology. 18: 248-51. PMID 9617985 DOI: 10.1097/00004714-199806000-00011  0.473
1998 Calvocoressi L, Libman D, Vegso SJ, McDougle CJ, Price LH. Global functioning of inpatients with obsessive-compulsive disorder, schizophrenia, and major depression. Psychiatric Services (Washington, D.C.). 49: 379-81. PMID 9525801 DOI: 10.1176/Ps.49.3.379  0.404
1998 Price LH, Malison RT, McDougle CJ, Pelton GH, Heninger GR. The neurobiology of tryptophan depletion in depression: effects of intravenous tryptophan infusion. Biological Psychiatry. 43: 339-47. PMID 9513749 DOI: 10.1016/S0006-3223(97)00284-9  0.349
1998 Mcdougle CJ, Brodkin ES, Naylor ST, Carlson DC, Cohen DJ, Price LH. Sertraline in adults with pervasive developmental disorders: A prospective open-label investigation Journal of Clinical Psychopharmacology. 18: 62-66. PMID 9472844 DOI: 10.1097/00004714-199802000-00010  0.379
1998 Price LH, Rasmussen SA. Stress and depression: is neuroimmunology the missing link? Harvard Review of Psychiatry. 5: 108-12. PMID 9385030 DOI: 10.3109/10673229709034736  0.413
1997 Price LH, Malison RT, McDougle CJ, McCance-Katz EF, Owen KR, Heninger GR. Neurobiology of tryptophan depletion in depression: effects of m-chlorophenylpiperazine (mCPP). Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 17: 342-50. PMID 9348549 DOI: 10.1016/S0893-133X(97)00084-5  0.403
1997 Gelernter J, Van Dyck C, van Kammen DP, Malison R, Price LH, Cubells JF, Berman R, Charney DS, Heninger G. Ciliary neurotrophic factor null allele frequencies in schizophrenia, affective disorders, and Alzheimer's disease. American Journal of Medical Genetics. 74: 497-500. PMID 9342199 DOI: 10.1002/(Sici)1096-8628(19970919)74:5<497::Aid-Ajmg8>3.0.Co;2-L  0.467
1997 Brodkin ES, McDougle CJ, Naylor ST, Cohen DJ, Price LH. Clomipramine in adults with pervasive developmental disorders: A prospective Open-Label investigation Journal of Child and Adolescent Psychopharmacology. 7: 109-121. PMID 9334896 DOI: 10.1089/Cap.1997.7.109  0.358
1997 Price LH, Cappiello A, Malison RT, McDougle CJ, Pelton GH, Schöllnhammer G, Heninger GR. Effects of antiglucocorticoid treatment on 5-HT1A function in depressed patients and healthy subjects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 17: 246-57. PMID 9326749 DOI: 10.1016/S0893-133X(97)00049-3  0.42
1997 Barr LC, Heninger GR, Goodman W, Charney DS, Price LH. Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects. Biological Psychiatry. 41: 949-54. PMID 9110100 DOI: 10.1016/S0006-3223(96)00224-7  0.581
1997 Bremner JD, Innis RB, Salomon RM, Staib LH, Ng CK, Miller HL, Bronen RA, Krystal JH, Duncan J, Rich D, Price LH, Malison R, Dey H, Soufer R, Charney DS. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Archives of General Psychiatry. 54: 364-74. PMID 9107153 DOI: 10.1001/Archpsyc.1997.01830160092012  0.53
1997 Kirwin PD, Anderson GM, Chappell PB, Saberski L, Leckman JF, Geracioti TD, Heninger GR, Price LH, McDougle CJ. Assessment of diurnal variation of cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in healthy human females. Life Sciences. 60: 899-907. PMID 9061047 DOI: 10.1016/S0024-3205(97)00021-0  0.308
1997 Cappiello A, Malison RT, McDougle CJ, Vegso SJ, Charney DS, Heninger GR, Price LH. Seasonal variation in neuroendocrine and mood responses to i.v. L-tryptophan in depressed patients and healthy subjects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 15: 475-83. PMID 8914120 DOI: 10.1016/S0893-133X(96)00057-7  0.553
1997 Epperson CN, McDougle CJ, Price LH. Intranasal oxytocin in trichotillomania. Biological Psychiatry. 40: 559-60. PMID 8879481 DOI: 10.1016/0006-3223(96)00165-5  0.495
1997 Epperson CN, McDougle CJ, Price LH. Intranasal oxytocin in obsessive-compulsive disorder. Biological Psychiatry. 40: 547-9. PMID 8879477 DOI: 10.1016/0006-3223(96)00120-5  0.555
1996 Price LH, Malison RT, McDougle CJ, Pelton GH. Antiglucocorticoids as Treatments for Depression Cns Drugs. 5: 311-320. PMID 26071044 DOI: 10.2165/00023210-199605050-00001  0.4
1996 McDougle CJ, Naylor ST, Cohen DJ, Volkmar FR, Heninger GR, Price LH. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder Archives of General Psychiatry. 53: 1001-1008. PMID 8911223 DOI: 10.1001/Archpsyc.1996.01830110037005  0.336
1996 McDougle CJ, Naylor ST, Cohen DJ, Aghajanian GK, Heninger GR, Price LH. Effects of tryptophan depletion in drug-free adults with autistic disorder. Archives of General Psychiatry. 53: 993-1000. PMID 8911222 DOI: 10.1001/Archpsyc.1996.01830110029004  0.368
1996 Carpenter LL, McDougle CJ, Epperson CN, Price LH. A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder. Drug Safety. 15: 116-34. PMID 8884163 DOI: 10.2165/00002018-199615020-00004  0.584
1996 McDougle CJ, Epperson CN, Price LH. Obsessive-compulsive symptoms with-neuroleptics. Journal of the American Academy of Child and Adolescent Psychiatry. 35: 837-8. PMID 8768337 DOI: 10.1097/00004583-199607000-00001  0.534
1996 Cappiello A, McDougle CJ, Malison RT, Heninger GR, Price LH. Yohimbine augmentation of fluvoxamine in refractory depression: a single-blind study. Biological Psychiatry. 38: 765-7. PMID 8580232 DOI: 10.1016/0006-3223(95)00367-3  0.393
1996 Epperson C, McDougle C, Ward-O’Brien D, Price L. Controlled study of antidepressant treatment of postpartum depression Biological Psychiatry. 39: 618. DOI: 10.1016/0006-3223(96)84346-0  0.614
1995 Price LH, Spencer DD, Marek KL, Robbins RJ, Leranth C, Farhi A, Naftolin F, Roth RH, Bunney BS, Hoffer PB. Psychiatric status after human fetal mesencephalic tissue transplantation in Parkinson's disease. Biological Psychiatry. 38: 498-505. PMID 8562661 DOI: 10.1016/0006-3223(95)00129-5  0.372
1995 Leckman JF, Goodman WK, Anderson GM, Riddle MA, Chappell PB, McSwiggan-Hardin MT, McDougle CJ, Scahill LD, Ort SI, Pauls DL, Cohen DJ, Price LH. Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, tourette's syndrome, and healthy controls Neuropsychopharmacology. 12: 73-86. PMID 7766289 DOI: 10.1038/Sj.Npp.1380241  0.32
1995 Krystal JH, Woods SW, Kosten TR, Rosen MI, Seibyl JP, van Dyck CC, Price LH, Zubal IG, Hoffer PB, Charney DS. Opiate dependence and withdrawal: preliminary assessment using single photon emission computerized tomography (SPECT). The American Journal of Drug and Alcohol Abuse. 21: 47-63. PMID 7762544 DOI: 10.3109/00952999509095229  0.451
1995 Anand A, Malison R, McDougle CJ, Price LH. Antiglucocorticoid treatment of refractory depression with ketoconazole: a case report. Biological Psychiatry. 37: 338-40. PMID 7748987 DOI: 10.1016/0006-3223(94)00245-X  0.371
1995 McDougle CJ, Kresch LE, Goodman WK, Naylor ST, Volkmar FR, Cohen DJ, Price LH. A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder American Journal of Psychiatry. 152: 772-777. PMID 7726318 DOI: 10.1176/Ajp.152.5.772  0.315
1995 Mcdougle CJ, Krystal JH, Price LH, Heninger GR, Charney DS. Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbine. Psychopharmacology. 118: 127-135. PMID 7617798 DOI: 10.1007/Bf02245830  0.435
1995 Goodman WK, McDougle CJ, Price LH, Barr LC, Hills OF, Caplik JF, Charney DS, Heninger GR. m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation. Biological Psychiatry. 38: 138-49. PMID 7578657 DOI: 10.1016/0006-3223(94)00235-U  0.508
1995 Goddard AW, Charney DS, Germine M, Woods SW, Heninger GR, Krystal JH, Goodman WK, Price LH. Effects of tryptophan depletion on responses to yohimbine in healthy human subjects Biological Psychiatry. 38: 74-85. PMID 7578653 DOI: 10.1016/0006-3223(94)00223-P  0.47
1995 McDougle CJ, Brodkin ES, Yeung PP, Naylor ST, Cohen DJ, Price LH. Risperidone in adults with autism or pervasive developmental disorder Journal of Child and Adolescent Psychopharmacology. 5: 273-282. DOI: 10.1089/Cap.1995.5.273  0.353
1994 Barr LC, Goodman WK, McDougle CJ, Delgado PL, Heninger GR, Charney DS, Price LH. Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors. Archives of General Psychiatry. 51: 309-17. PMID 8161291 DOI: 10.1001/Archpsyc.1994.03950040053007  0.51
1994 McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Archives of General Psychiatry. 51: 302-8. PMID 8161290 DOI: 10.1001/Archpsyc.1994.03950040046006  0.36
1994 Calvocoressi L, McDougle CI, Wasylink S, Goodman WK, Trufan SJ, Price LH. Inpatient treatment of patients with severe obsessive-compulsive disorder. Hospital & Community Psychiatry. 44: 1150-4. PMID 8132187 DOI: 10.1176/Ps.44.12.1150  0.336
1994 Price LH, Heninger GR. Lithium in the treatment of mood disorders. The New England Journal of Medicine. 331: 591-8. PMID 8047085 DOI: 10.1056/Nejm199409013310907  0.331
1994 Holzer JC, Goodman WK, McDougle CJ, Baer L, Boyarsky BK, Leckman JF, Price LH. Obsessive-compulsive disorder with and without a chronic tic disorder. A comparison of symptoms in 70 patients. The British Journal of Psychiatry : the Journal of Mental Science. 164: 469-73. PMID 8038934 DOI: 10.1192/Bjp.164.4.469  0.35
1994 Delgado PL, Price LH, Miller HL, Salomon RM, Aghajanian GK, Heninger GR, Charney DS. Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. Archives of General Psychiatry. 51: 865-74. PMID 7944875 DOI: 10.1001/Archpsyc.1994.03950110025005  0.562
1994 Anand A, Charney DS, Delgado PL, McDougle CJ, Heninger GR, Price LH. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects. The American Journal of Psychiatry. 151: 1626-30. PMID 7943451 DOI: 10.1176/Ajp.151.11.1626  0.539
1994 Goddard AW, Sholomskas DE, Walton KE, Augeri FM, Charney DS, Heninger GR, Goodman WK, Price LH. Effects of tryptophan depletion in panic disorder. Biological Psychiatry. 36: 775-7. PMID 7858076 DOI: 10.1016/0006-3223(94)90091-4  0.475
1994 Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, Anderson GM, Riddle MA, McSwiggan-Hardin M, McDougle CJ, Barr LC, Cohen DJ. Elevated Cerebrospinal Fluid Levels of Oxytocin in Obsessive-compulsive Disorder: Comparison with Tourette's Syndrome and Healthy Controls Archives of General Psychiatry. 51: 782-792. PMID 7524462 DOI: 10.1001/Archpsyc.1994.03950100030003  0.321
1994 EPPERSON CN, McDOUGLE CJ, ANAND A, MAREK GJ, NAYLOR ST, VOLKMAR FR, COHEN DJ, PRICE LH. Lithium Augmentation of Fluvoxamine in Autistic Disorder: A Case Report Journal of Child and Adolescent Psychopharmacology. 4: 201-207. DOI: 10.1089/Cap.1994.4.201  0.58
1994 Goddard A, Woods S, Goodman W, Price L, Heninger G. Responses To Yohimbine in Social Phobia Neuropsychopharmacology. 11: 270-270. DOI: 10.1038/Sj.Npp.1380155  0.307
1994 McDougle CJ, Price LH, Volkmar FR. Recent Advances in the Pharmacotherapy of Autism and Related Conditions Child and Adolescent Psychiatric Clinics of North America. 3: 71-89. DOI: 10.1016/S1056-4993(18)30516-9  0.307
1993 Zimmermann RC, McDougle CJ, Schumacher M, Olcese J, Mason JW, Heninger GR, Price LH. Effects of acute tryptophan depletion on nocturnal melatonin secretion in humans. The Journal of Clinical Endocrinology and Metabolism. 76: 1160-4. PMID 8496306 DOI: 10.1210/Jcem.76.5.8496306  0.358
1993 McDougle CJ, Goodman WK, Leckman JF, Holzer JC, Barr LC, McCance-Katz E, Heninger GR, Price LH. Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder. The American Journal of Psychiatry. 150: 647-9. PMID 8465885 DOI: 10.1176/ajp.150.4.647  0.311
1993 McDougle CJ, Goodman WK, Price LH. The pharmacotherapy of obsessive-compulsive disorder. Pharmacopsychiatry. 24-9. PMID 8378419 DOI: 10.1055/S-2007-1014373  0.361
1993 Barr LC, Goodman WK, Price LH. The serotonin hypothesis of obsessive compulsive disorder. International Clinical Psychopharmacology. 8: 79-82. PMID 8201248 DOI: 10.1097/00004850-199311002-00011  0.302
1993 Krystal JH, Seibyl JP, Price LH, Woods SW, Heninger GR, Aghajanian GK, Charney DS. m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia. Archives of General Psychiatry. 50: 624-35. PMID 8102048 DOI: 10.1001/Archpsyc.1993.01820200034004  0.504
1993 McCance-Katz EF, Marek KL, Price LH. Serotonin, depression, and PD Neurology. 43: 1625-1625. DOI: 10.1212/Wnl.43.8.1625  0.32
1993 McDOUGLE CJ, GOODMAN WK, LECKMAN JF, BARR LC, HENINGER GR, PRICE LH. The Efficacy of Fluvoxamine in Obsessive-Compulsive Disorder Journal of Clinical Psychopharmacology. 13: 354???358. DOI: 10.1097/00004714-199310000-00008  0.353
1993 McDougle CJ, Goodman WK, Leckman JF, Price LH. The Psychopharmacology of Obsessive Compulsive Disorder: Implications for Treatment and Pathogenesis Psychiatric Clinics of North America. 16: 749-766. DOI: 10.1016/S0193-953X(18)30148-5  0.335
1992 McDougle CJ, Price LH, Volkmar FR, Goodman WK, Ward-O'Brien D, Nielsen J, Bregman J, Cohen DJ. Clomipramine in autism: preliminary evidence of efficacy. Journal of the American Academy of Child and Adolescent Psychiatry. 31: 746-50. PMID 1644740 DOI: 10.1097/00004583-199207000-00025  0.369
1992 McCance-Katz EF, Price LH. Depression associated with vitamin A intoxication. Psychosomatics. 33: 117-8. PMID 1539094 DOI: 10.1016/S0033-3182(92)72033-7  0.346
1992 Heninger GR, Delgado PL, Charney DS, Price LH, Aghajanian GK. Tryptophan-deficient diet and amino acid drink deplete plasma tryptophan and induce a relapse of depression in susceptible patients. Journal of Chemical Neuroanatomy. 5: 347-8. PMID 1524722 DOI: 10.1016/0891-0618(92)90025-L  0.479
1992 McCance-Katz E, Price LH, Charney DS, Heninger GR. Serotonergic function during lithium augmentation of refractory depression Psychopharmacology. 108: 93-97. PMID 1410150 DOI: 10.1007/Bf02245291  0.546
1992 McCance-Katz EF, Marek KL, Price LH. Serotonergic dysfunction in depression associated with Parkinson's disease. Neurology. 42: 1813-4. PMID 1387464 DOI: 10.1212/Wnl.42.9.1813  0.401
1992 Marek GJ, McDougle CJ, Price LH, Seiden LS. A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action. Psychopharmacology. 109: 2-11. PMID 1365657 DOI: 10.1007/Bf02245475  0.314
1992 Krystal JH, Price LH, Opsahl C, Ricaurte GA, Heninger GR. Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function? The American Journal of Drug and Alcohol Abuse. 18: 331-41. PMID 1357957 DOI: 10.3109/00952999209026070  0.323
1992 Krystal JH, McDougle CJ, Woods SW, Price LH, Heninger GR, Charney DS. Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine Psychopharmacology. 108: 313-319. PMID 1355923 DOI: 10.1007/Bf02245117  0.468
1992 Krystal JH, McDougle CJ, Kosten TR, Price LH, Aghajanian GK, Charney DS. Baclofen-assisted detoxification from opiates. A pilot study. Journal of Substance Abuse Treatment. 9: 139-42. PMID 1324986 DOI: 10.1016/0740-5472(92)90081-X  0.458
1992 Goodman WK, Mcdougle CJ, Price LH. Pharmacotherapy of obsessive compulsive disorder. The Journal of Clinical Psychiatry. 53: 29-37. DOI: 10.1007/978-3-642-77608-3_13  0.386
1991 Delgado PL, Goodman WK, Price LH, Heninger GR, Charney DS. Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorder. The British Journal of Psychiatry : the Journal of Mental Science. 157: 762-5. PMID 2126219 DOI: 10.1192/Bjp.157.5.762  0.492
1991 Satel SL, Price LH, Palumbo JM, McDougle CJ, Krystal JH, Gawin F, Charney DS, Heninger GR, Kleber HD. Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. The American Journal of Psychiatry. 148: 1712-6. PMID 1957935 DOI: 10.1176/Ajp.148.12.1712  0.415
1991 Price LH, Charney DS, Delgado PL, Heninger GR. Serotonin function and depression: neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects American Journal of Psychiatry. 148: 1518-1525. PMID 1928466 DOI: 10.1176/Ajp.148.11.1518  0.557
1991 Seibyl JP, Krystal JH, Price LH, Woods SW, D'Amico C, Heninger GR, Charney DS. Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects Psychiatry Research. 38: 227-236. PMID 1754635 DOI: 10.1016/0165-1781(91)90013-F  0.469
1991 Hand I, Linden M, Simons G, Hautzinger M, Heckel-Guhrenz S, Kraemer S, Schickor I, Rief W, Leibl C, Fichter MM, Büttner-Westphal H, Goodman W, Rasmussen S, Price L, Mazure L, et al. Ausbildungsinstitut für Klinische Verhaltenstherapie in NRW (AFKV in NRW e.V.) Verhaltenstherapie. 1: 256-256. DOI: 10.1159/000257983  0.363
1991 Hand I, Linden M, Simons G, Hautzinger M, Heckel-Guhrenz S, Kraemer S, Schickor I, Rief W, Leibl C, Fichter MM, Büttner-Westphal H, Goodman W, Rasmussen S, Price L, Mazure L, et al. Bayerische Private Akademie für Psychotherapie (BAP) Verhaltenstherapie. 1: 162-162. DOI: 10.1159/000257976  0.397
1991 Goodman W, Rasmussen S, Price L, Mazure L, Heninger G, Charney D. Yale-Brown Obsessive Compulsive Scale (Y-BOCS) Verhaltenstherapie. 1: 226-233. DOI: 10.1159/000257973  0.392
1991 McDOUGLE CJ, PRICE LH, GOODMAN WK, CHARNEY DS, HENINGER GR. A Controlled Trial of Lithium Augmentation in Fluvoxamine-Refractory Obsessive-Compulsive Disorder Journal of Clinical Psychopharmacology. 11: 175???184. DOI: 10.1097/00004714-199106000-00005  0.547
1991 Malison RT, Price LH. Panic disorder Current Opinion in Psychiatry. 4: 255-261. DOI: 10.1097/00001504-199104000-00012  0.307
1991 Krystal J, Seibyl J, Price L, Woods S, Heninger G, Charney D. MCPP effects in schizophrenic patients before and after typical and atypical neuroleptic treatment Schizophrenia Research. 4: 350. DOI: 10.1016/0920-9964(91)90266-T  0.456
1990 Heninger GR, Charney DS, Price LH, Delgado P, Woods S, Goodman W. Effects of serotonergic agonists on neuroendocrine responses of rhesus monkeys and patients with depression and anxiety disorders. Psychopharmacology Series. 7: 94-104. PMID 2687871 DOI: 10.1007/978-3-642-74430-3_10  0.513
1990 Delgado PL, Charney DS, Price LH, Landis H, Heninger GR. Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects. Life Sciences. 45: 2323-32. PMID 2601581 DOI: 10.1016/0024-3205(89)90114-8  0.421
1990 Price LH, Charney DS, Delgado PL, Heninger GR. Lithium and serotonin function: implications for the serotonin hypothesis of depression Psychopharmacology. 101: 3-12. PMID 2404294 DOI: 10.1007/Bf02245781  0.493
1990 Kosten TR, Krystal JH, Charney DS, Price LH, Morgan CH, Kleber HD. Opioid antagonist challenges in buprenorphine maintained patients. Drug and Alcohol Dependence. 25: 73-8. PMID 2323312 DOI: 10.1016/0376-8716(90)90144-4  0.447
1990 Price LH, Charney DS, Delgado PL, Heninger GR. Fenfluramine augmentation in tricyclic-refractory depression Journal of Clinical Psychopharmacology. 10: 312-317. PMID 2258448 DOI: 10.1097/00004714-199010000-00002  0.555
1990 Price LH, Charney DS, Delgado PL, Goodman WK, Krystal JH, Woods SW, Heninger GR. Clinical studies of 5-HT function using I.V. l-Tryptophan Progress in Neuropsychopharmacology and Biological Psychiatry. 14: 459-472. PMID 2236580 DOI: 10.1016/0278-5846(90)90002-X  0.474
1990 Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Archives of General Psychiatry. 47: 411-8. PMID 2184795 DOI: 10.1001/Archpsyc.1990.01810170011002  0.535
1990 Nierenberg AA, Price LH, Charney DS, Heninger GR. After lithium augmentation: a retrospective follow-up of patients with antidepressant-refractory depression Journal of Affective Disorders. 18: 167-175. PMID 2139061 DOI: 10.1016/0165-0327(90)90033-5  0.529
1990 McDougle CJ, Price LH, Goodman WK. Fluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder: a case report. Journal of Autism and Developmental Disorders. 20: 537-543. PMID 2126264 DOI: 10.1007/Bf02216058  0.318
1990 Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR, Charney DS. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Archives of General Psychiatry. 47: 577-85. PMID 2112374 DOI: 10.1001/Archpsyc.1990.01810180077011  0.565
1990 McDougle CJ, Goodman WK, Price LH, Delgado PL, Krystal JH, Charney DS, Heninger GR. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. The American Journal of Psychiatry. 147: 652-4. PMID 1970224 DOI: 10.1176/Ajp.147.5.652  0.494
1990 Price L. Serotonin Reuptake Inhibitors in Depression and Anxiety: An Overview Annals of Clinical Psychiatry. 2: 165-172. DOI: 10.3109/10401239009147940  0.39
1990 Price LH, Charney DS, Delgado PL, Heninger GR. Lithium Treatment Effect on Serotonin Function Archives of General Psychiatry. 47: 290. DOI: 10.1001/Archpsyc.1990.01810150090017  0.462
1989 Price LH, Charney DS, Delgado PL, Heninger GR. Lithium Treatment and Serotoninergic Function: Neuroendocrine and Behavioral Responses to Intravenous Tryptophan in Affective Disorder Archives of General Psychiatry. 46: 13-19. PMID 2910219 DOI: 10.1001/Archpsyc.1989.01810010015002  0.497
1989 Price LH. What is the duration for augmentation with T3 or lithium in resistant depression? Journal of Clinical Psychopharmacology. 9: 73. PMID 2708563 DOI: 10.1097/00004714-198902000-00031  0.331
1989 Seibyl JP, Krystal JH, Price LH, Charney DS. Use of yohimbine to counteract nortriptyline-induced orthostatic hypotension Journal of Clinical Psychopharmacology. 9: 67-68. PMID 2708559 DOI: 10.1097/00004714-198902000-00026  0.389
1989 Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry. 46: 1006-11. PMID 2684084 DOI: 10.1001/Archpsyc.1989.01810110048007  0.467
1989 Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale. II. Validity. Archives of General Psychiatry. 46: 1012-6. PMID 2510699 DOI: 10.1001/Archpsyc.1989.01810110054008  0.517
1989 Price LH, Charney DS, Delgado PL, Anderson GM, Heninger GR. Effects of desipramine and fluvoxamine treatment on the prolactin response to tryptophan. Serotonergic function and the mechanism of antidepressant action. Archives of General Psychiatry. 46: 625-31. PMID 2500111 DOI: 10.1001/Archpsyc.1989.01810070051009  0.487
1989 Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS. Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. Archives of General Psychiatry. 46: 36-44. PMID 2491940 DOI: 10.1001/Archpsyc.1989.01810010038006  0.58
1989 Goodman WK, Price LH, Charney DS. Fluvoxamine in Obsessive Compulsive Disorder Psychiatric Annals. 19: 92-96. DOI: 10.3928/0048-5713-19890201-10  0.463
1989 Heninger G, Delgado P, Charney D, Price L, Aghajanian G, Landis H. Behavioral effects of acute tryptophan depletion in depressed patients Biological Psychiatry. 25: A143. DOI: 10.1016/0006-3223(89)91774-5  0.52
1988 Price LH, Charney DS, Heninger GR. Effects of trazodone treatment on serotonergic function in depressed patients Psychiatry Research. 24: 165-175. PMID 3406237 DOI: 10.1016/0165-1781(88)90059-5  0.526
1988 Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR. Serotonin Function in Obsessive-Compulsive Disorder: A Comparison of the Effects of Tryptophan and m-Chlorophenylpiperazine in Patients and Healthy Subjects Archives of General Psychiatry. 45: 177-185. PMID 3337615 DOI: 10.1001/Archpsyc.1988.01800260095012  0.488
1988 Heninger GR, Charney DS, Price LH. Noradrenergic and serotonergic receptor system function in panic disorder and depression Acta Psychiatrica Scandinavica. 77: 138-150. PMID 3048049 DOI: 10.1111/J.1600-0447.1988.Tb08559.X  0.583
1988 Delgado PL, Price LH, Charney DS, Heninger GR. Efficacy of fluvoxamine in treatment-refractory depression Journal of Affective Disorders. 15: 55-60. PMID 2970493 DOI: 10.1016/0165-0327(88)90009-2  0.538
1988 Heninger GR, Charney DS, Price LH. α2-Adrenergic Receptor Sensitivity in Depression: The Plasma MHPG, Behavioral, and Cardiovascular Responses to Yohimbine Archives of General Psychiatry. 45: 718-726. PMID 2840050 DOI: 10.1001/Archpsyc.1988.01800320028003  0.576
1988 Price LH. The Measurement of Depression: Clinical, Biological, Psychological and Psychosocial Perspectives The Journal of Nervous and Mental Disease. 176: 701. DOI: 10.1097/00005053-198811000-00015  0.369
1988 Charney DS, Price LH, Breier A. The Course of Panic Attacks and Agoraphobia-Reply Archives of General Psychiatry. 45: 502. DOI: 10.1001/Archpsyc.1988.01800290124016  0.523
1987 Price LH, Goodman WK, Charney DS, Rasmussen SA, Heninger GR. Treatment of severe obsessive-compulsive disorder with fluvoxamine. The American Journal of Psychiatry. 144: 1059-61. PMID 3111279 DOI: 10.1176/ajp.144.8.1059  0.438
1987 Price LH, Charney DS, Heninger GR. Reserpine augmentation of desipramine in refractory depression: clinical and neurobiological effects Psychopharmacology. 92: 431-437. PMID 2442788 DOI: 10.1007/Bf00176473  0.556
1986 Mazure C, Nelson JC, Price LH. Reliability and validity of the symptoms of major depressive illness. Archives of General Psychiatry. 43: 451-6. PMID 3964024 DOI: 10.1001/Archpsyc.1986.01800050053006  0.361
1986 Innis RB, Bunney BS, Charney DS, Price LH, Glazer WM, Sternberg DE, Rubin AL, Heninger GR. Does the cholecystokinin antagonist proglumide possess antipsychotic activity? Psychiatry Research. 18: 1-7. PMID 3737785 DOI: 10.1016/0165-1781(86)90056-9  0.444
1986 Price LH, Charney DS, Heninger GR. Variability of response to lithium augmentation in refractory depression American Journal of Psychiatry. 143: 1387-1392. PMID 3096155 DOI: 10.1176/Ajp.143.11.1387  0.531
1986 Charney DS, Price LH, Heninger GR. Desipramine-Yohimbine Combination Treatment of Refractory Depression: Implications for the β-Adrenergic Receptor Hypothesis of Antidepressant Action Archives of General Psychiatry. 43: 1155-1161. PMID 3022664 DOI: 10.1001/Archpsyc.1986.01800120041009  0.519
1986 Price LH, Charney DS, Rubin AL, Heninger GR. α2-Adrenergic Receptor Function in Depression: The Cortisol Response to Yohimbine Archives of General Psychiatry. 43: 849-858. PMID 3019271 DOI: 10.1001/Archpsyc.1986.01800090035006  0.534
1986 Price LH, Charney DS, Heninger GR. Effects of trazodone treatment on alpha-2 adrenoceptor function in depressed patients Psychopharmacology. 89: 38-44. PMID 3016788 DOI: 10.1007/Bf00175186  0.502
1986 Goodman WK, Charney DS, Price LH, Woods SW, Heninger GR. Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: Report of three cases American Journal of Psychiatry. 143: 900-903. PMID 2872826 DOI: 10.1176/Ajp.143.7.900  0.457
1985 Price LH, Charney DS, Heninger GR. Effects of tranylcypromine treatment on neuroendocrine, behavioral, and autonomic responses to tryptophan in depressed patients Life Sciences. 37: 809-818. PMID 4033356 DOI: 10.1016/0024-3205(85)90515-6  0.557
1985 Price LH, Charney DS, Heninger GR. Efficacy of lithium-tranylcypromine treatment in refractory depression American Journal of Psychiatry. 142: 619-623. PMID 3920923 DOI: 10.1176/Ajp.142.5.619  0.54
1985 Lawrence Rubin A, Price LH, Charney DS, Heninger GR. Noradrenergic function and the cortisol response to dexamethasone in depression Psychiatry Research. 15: 5-15. PMID 2989963 DOI: 10.1016/0165-1781(85)90034-4  0.555
1984 Price LH, Craig Nelson J, Charney DS, Quinlan DM. The clinical utility of family history for the diagnosis of melancholia Journal of Nervous and Mental Disease. 172: 5-11. PMID 6690653  0.456
1984 Price LH, Charney DS, Heninger GR. Manic symptoms following addition of lithium to antidepressant treatment Journal of Clinical Psychopharmacology. 4: 361-362. PMID 6512008 DOI: 10.1097/00004714-198412000-00020  0.495
1984 Price LH, Nelson JC, Charney DS, Quinlan DM. Family history in delusional depression Journal of Affective Disorders. 6: 109-114. PMID 6231325 DOI: 10.1016/0165-0327(84)90012-0  0.526
1984 Price LH, Charney DS, Heninger GR. Three cases of manic symptoms following yohimbine administration American Journal of Psychiatry. 141: 1267-1268. PMID 6091464 DOI: 10.1176/Ajp.141.10.1267  0.457
1983 Price LH, Conwell Y, Nelson JC. Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression. The American Journal of Psychiatry. 140: 318-22. PMID 6131612 DOI: 10.1097/00004714-198308000-00023  0.424
1982 Leigh H, Price L, Ciarcia J, Mirassou MM. DSM III and consultation-liaison psychiatry: toward a comprehensive medical model of the patient. General Hospital Psychiatry. 4: 283-289. PMID 7152251 DOI: 10.1016/0163-8343(82)90087-1  0.32
Show low-probability matches.